TOP STORIES

• REGULATORY PD-L1 Expression Testing Won’t Be a Must for Opdivo, but Clarification Needed: Chuikyo
  December 15, 2016

• REGULATORY MHLW Drafts Optimal Use Guidelines for Opdivo in NSCLC
  December 14, 2016

• REGULATORY Survey Method, Product Scope for Annual Revisions to Be Discussed in 2017
  December 14, 2016

• BUSINESS Aspen Japan Starting on Right Foot on AG Biz: GSK Japan President
  December 13, 2016

• REGULATORY Chuikyo Reps, Distributors Fret Market Prices Will Be Kept High with Annual Revisions
  December 12, 2016

• REGULATORY (Update) “2%” Adjustment Rate Should Be Made a Discussion Point for Annual Revisions: Chuikyo Rep
  December 12, 2016

• REGULATORY Govt Eyes “Bailout Measures” for Products with Small NHI-Market Price Gaps in Annual Revision Plan
  December 9, 2016

• REGULATORY Shiozaki, Govt Panel Agree on Annual Price Reviews, but Scope of Drugs Still Unclear
  December 8, 2016

• BUSINESS Mitsubishi Tanabe Fending Off Inroads from Biosimilars through Add’l Indications for Remicade
  December 8, 2016

• REGULATORY LDP Tax Panel OKs Refit of R&D Tax Credit System in FY2017
  December 7, 2016

• BUSINESS Acquisition of Long-Listed Drugs to Promote Generic Sales; Sales Target of 50 Billion Yen “in Range”: Kyowa Pharm
  December 7, 2016

• ORGANIZATION Drug Pricing Policy Can’t Be Defined in 2-3 Weeks: PhRMA Exec
  December 6, 2016

• BUSINESS Chugai to Enter Hemophilia Field with Emicizumab; Peak Sales Could Top 200 Billion Yen
  December 6, 2016

• REGULATORY PM Abe’s Council to Discuss Annual Drug Price Revisions Again on Dec. 7
  December 5, 2016

• INTERVIEW Interview: Metgluco, AGs, and Diagnostics 3 Biz Pillars for New Sumitomo Dainippon Subsidiary
  December 2, 2016

• REGULATORY Industry, Healthcare Provider Reps Oppose “Annual Revisions” as Payers Hold Off Stance: Chuikyo
  December 1, 2016

• REGULATORY Chuikyo to Discuss “Price-Setting Including NHI Price Increases” Using Cost-Effective Assessments
  December 1, 2016

• REGULATORY “Outright” or “Partial”? Annual Revision Debate Rekindled in a Rush to Revamp Drug Pricing
  November 30, 2016

• BUSINESS Signs of Growth in Prescribing SGLT-2 Inhibitors with Favorable Environment Change
  November 30, 2016

• BUSINESS Ono to Offer New Invoice Prices for Opdivo Early on to Avoid Distribution Confusion
  November 29, 2016

ページ

• « 先頭
• ‹ Prev
• …
• 168
• 169
• 170
• 171
• 172
• 173
• 174
• 175
• 176
• …
• Next ›
• 最終 »